Altogether, our observations rather suggest a tumor spectrum restricted to childhood MB, and the tumor-free survival in ELP1-variant carriers (Figure 3C) indicates that the risk may be limited to the first 15 years of life. This evidence concerns the gene ELP1 and neoplasm.